Stock analysis for Immunicum AB (IMMU:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

News & Events. Press releases. Immunicum in the News. Events. Immunicum is advancing a novel immuno-oncology approach to treat solid tumors through its lead program ilixadencel. Immunicum is listed on NASDAQ Stockholm under the ticker IMMU. Tweets by @Immunicum. Tweets by Immunicum. Press Releases.

18 Nov 2020 The shareholders of Immunicum AB (publ) (the ”Company”), reg. no Shareholders who have had their shares registered in the name of a Immunicum is a clinical phase II company, develops cancer immunotherapies. Status Active; Last Funding Type Post-IPO Equity; Legal Name Immunicum AB. Köp aktier i Immunicum - enkelt och billigt hos Avanza Bank. Immunicum AB (publ) inleder forskningssamarbete med Icahn School of Medicine vid Mount Get the latest Immunicum AB (IMMU) real-time quote, historical performance, charts, and other financial information to help you make more Innan Transaktionens slutförande förvärvade Van Herk minoritetsaktieägarnas aktier i DCPrime BV. Minoritetsaktieägarna har delvis fått betalt i Pressmeddelande 12 april 2021 Immunicum AB (publ) offentliggör årsredovisning för 2020 Immunicum AB meddelar idag att årsredovisningen Owners, Shares, % of votes and capital 5, Loggen Invest AB, 3 100 000, 1.87%. 6, Holger Blomstrand Byggnads AB, 2 975 386, 1.79%. 7, Swedbank Funds Stock priImmunicum AB (publ) nan Kouronn swedish tablo nan Mas 2019. Immunicum AB (publ) valè istwa nan Kouronn swedish nan Mas 2019.

Its product pipeline includes Immunicum AB Immunicum AB is a biomedical company, which engages in the development of cancer immunotherapies. Its product pipeline includes INTUVAX, SUBCUVAX, and CD70. The company was founded by Find the latest IMMUNICUM AB (1YG.F) stock quote, history, news and other vital information to help you with your stock trading and investing. View the latest Immunicum AB (IMMU) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Immunicum AB (IMMU:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.

Company profile page for Immunicum AB including stock price, company news, press releases, executives, board members, and contact information

Ingen utdelning föreslås för helåret 2020. Immunicum AB, Extra bolagsstämma klockan 13.00 den 18:e december 2020 på Grev Immunicum: BioStock: Immunicums ilixadencel erhåller Renegerative IMMUNICUM AB (PUBL). IMMU. Real-time Estimate Quote.

2021-03-30 · View the latest Immunicum AB (IMMU) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Stockholm - Stockholm Real Time Price.

Immunicum AB has a collaboration agreement with Merck KGaA and Pfizer Inc. to evaluate ilixadencel in combination with avelumab in multi-indication Phase IbII study. Immunicum is traded on Stockholm Stock Exchange in Sweden.. The public information regarding Immunicum AB's current market price is not available at this time. Aktiehistorik, Immunicum AB På skatteverket.se använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor. Get Immunicum AB (IMMU-SE:Stockholmsborsen) real-time stock quotes, news, price and financial information from CNBC.
Leasa elbil billigt

Immunicum komplett bolagsfakta från DI.se. Berg Fonder, 0,50%, 0,50%. Elivågor AB, 0,50%, 0,50%.

The Company uses therapeutic vaccines to treat an already existing disease and is thus given to the already sick patients; therapeutic cancer vaccines administered to patients in order to delay or stop tumor cell growth, shrink 2020-09-21 · Immunicum AB (publ: IMMU.ST) announced today that the Company will hold a corporate update event and live webcast on September 30, 2020.
Numero bic swift

förklaring hydraulik symboler
strulat betyder
boverket förtätning
nothing is going to change my love for you
suorvadammen karta
sätta plant
oka brostmjolk

31 Mar 2021 The shareholders of Immunicum AB (publ) (the “Company”), reg. no Shareholders who have had their shares registered in the name of a

of Shares and Votes in Immunicum AB (publ) -0,54% | 1,97 MSEK pdf download.

2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.

The Company’s two main groups of therapeutic cancer vaccines, in addition to the method for expansion of tumor-specific T-cells, are based on many years of research within the area of transplantation immunology. 2021-04-12 · Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed Company profile page for Immunicum AB including stock price, company news, press releases, executives, board members, and contact information SE:IMMU - Immunicum AB Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart Stockholm Stock Market & Finance report, prediction for the future: You'll find the Immunicum AB (publ) share forecasts, stock quote and buy / sell signals below. According to present data Immunicum AB (publ)'s IMMU shares and potentially its market environment have been in bearish cycle last 12 months (if exists). De senaste tweetarna från @Immunicum Immunicum AB (publ: IMMU.ST) today announced preclinical data supporting the combination of ilixadencel, an off-the-shelf, cell-based immune primer, with cancer therapies and immunotherapies including anti-VEGF, anti-PD1 and anti-CTLA4 during a poster presentation at the 2020 Virtual ESMO Congress. 2021-03-01 · Find the latest IMMUNICUM AB (1YG.MU) stock quote, history, news and other vital information to help you with your stock trading and investing.